Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
Karen B JacobsonBenjamin A PinskyMaria E Montez RathHannah WangJacob A MillerMehdi SkhiriJohn ShepardRoshni MathewGrace LeeBryan BohmanJulie ParsonnetMarisa K HolubarPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Most PVSCs occurred prior to expected onset of full, vaccine-derived immunity. Presumptive B.1.427/B.1.429 was not more prevalent in post-vaccine cases than in unvaccinated SARS-CoV-2 HCP. Continued infection control measures, particularly ≤14 days post-vaccination, and continued variant surveillance in PVSCs is imperative to control future SARS-CoV-2 surges.